• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中左旋多巴诱发的异动症:现象学与病理生理学

Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.

作者信息

Marconi R, Lefebvre-Caparros D, Bonnet A M, Vidailhet M, Dubois B, Agid Y

机构信息

INSERM U 289, Hôpital de la Salpêtrière, Paris, France.

出版信息

Mov Disord. 1994 Jan;9(1):2-12. doi: 10.1002/mds.870090103.

DOI:10.1002/mds.870090103
PMID:8139601
Abstract

The aim of this study was to provide further insight into the phenomenology and pathophysiology of monophasic and biphasic dyskinesias induced by levodopa in Parkinson's disease. For this purpose, the type, localization, severity, and timing of dyskinesias were evaluated in 15 parkinsonian patients in relation to motor disability after administration of levodopa using a video-electromyographic recording device. Foot-dystonia, myoclonus, and akathisia were observed in most patients. The dyskinesias started in the foot, usually on the side most affected by the disease, and spread in an "ascending wave" to the contralateral side, the trunk, and upper extremities. In a few patients, onset was axial, spreading almost instantaneously to all limbs. The dyskinesias were dystonic and ballistic at the start, and became increasingly choreic as they attained the upper limbs. Their intensity was maximal in the lower limbs, then progressively decreased, while increasing in upper limbs and head. The results indicate that there is no strict dichotomy between biphasic and monophasic dyskinesias. In other words, there is a "continuum" between the first dyskinesias and those observed during the period of maximal clinical improvement. These dyskinesias can also appear in reverse order, as if there were an "oscillator" determining a sequence of alternating patterns.

摘要

本研究的目的是进一步深入了解帕金森病中左旋多巴诱发的单相和双相异动症的现象学和病理生理学。为此,使用视频肌电图记录设备,对15例帕金森病患者在服用左旋多巴后与运动功能障碍相关的异动症类型、部位、严重程度和发作时间进行了评估。大多数患者观察到足部肌张力障碍、肌阵挛和静坐不能。异动症始于足部,通常在疾病最严重的一侧,然后以“上升波”的形式扩散到对侧、躯干和上肢。少数患者的发作起始于躯干,几乎瞬间扩散到所有肢体。异动症开始时为张力障碍性和弹道性,随着累及上肢,逐渐变得越来越像舞蹈样动作。其强度在下肢最大,然后逐渐降低,而上肢和头部的强度则增加。结果表明,双相和单相异动症之间没有严格的二分法。换句话说,首次出现的异动症与临床改善最大期观察到的异动症之间存在“连续体”。这些异动症也可能以相反的顺序出现,就好像有一个“振荡器”决定了交替模式的序列。

相似文献

1
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.帕金森病中左旋多巴诱发的异动症:现象学与病理生理学
Mov Disord. 1994 Jan;9(1):2-12. doi: 10.1002/mds.870090103.
2
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.帕金森病中左旋多巴诱导的异动症:临床与药理学分类
Mov Disord. 1992;7(2):117-24. doi: 10.1002/mds.870070204.
3
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.晚期帕金森病的严重夜间异动症:临床描述、与血浆左旋多巴的关系及治疗
Mov Disord. 1994 Mar;9(2):173-7. doi: 10.1002/mds.870090208.
4
[Dyskinesia caused by L-DOPA].[左旋多巴引起的运动障碍]
Rev Neurol (Paris). 2002 Dec;158 Spec no 1:S92-101.
5
Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).长期给予左旋多巴会在1-甲基-4-苯基-1,2,3,6-四氢吡啶处理的普通狨猴(绢毛猴)中诱发运动障碍。
Mov Disord. 1995 Nov;10(6):731-40. doi: 10.1002/mds.870100606.
6
Striatal dopaminoceptive system changes and motor response complications in L-dopa-treated patients with advanced Parkinson's disease.左旋多巴治疗的晚期帕金森病患者纹状体多巴胺感受系统变化及运动反应并发症
Adv Neurol. 1993;60:181-5.
7
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.帕金森病双侧丘脑底核毁损术:初始及长期疗效
Brain. 2005 Mar;128(Pt 3):570-83. doi: 10.1093/brain/awh397. Epub 2005 Feb 2.
8
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin.肉毒杆菌毒素治疗帕金森病中的“关闭期”疼痛性肌张力障碍
Mov Disord. 1995 May;10(3):333-6. doi: 10.1002/mds.870100317.
9
Clinical aspects of motor fluctuations in Parkinson's disease.帕金森病运动波动的临床特征
Neurology. 1994 Jul;44(7 Suppl 6):S6-9.
10
Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?帕金森病中左旋多巴诱发的异动症:敏化作用是否可逆?
Ann Neurol. 2000 May;47(5):655-8.

引用本文的文献

1
Digital speech biomarkers can measure acute effects of levodopa in Parkinson's disease.数字语音生物标志物可测量左旋多巴对帕金森病的急性影响。
NPJ Parkinsons Dis. 2025 Jul 1;11(1):184. doi: 10.1038/s41531-025-01045-5.
2
Drug-Induced Myoclonus: A Systematic Review.药物性肌阵挛:一项系统评价
Medicina (Kaunas). 2025 Jan 15;61(1):131. doi: 10.3390/medicina61010131.
3
Quality of Life after Deep Brain Stimulation in Parkinson's Disease: Does the Target Matter?帕金森病深部脑刺激术后生活质量:靶点重要吗?
Mov Disord Clin Pract. 2024 Nov;11(11):1379-1387. doi: 10.1002/mdc3.14199. Epub 2024 Sep 3.
4
Japanese Mucuna pruriens (Hasshou Beans) Showed Fast-acting and Long-lasting Effects in Parkinson's Disease.日本黎豆(含羞草)在帕金森病中显示出快速起效和持久的效果。
Intern Med. 2024 Oct 15;63(20):2773-2779. doi: 10.2169/internalmedicine.3171-23. Epub 2024 Mar 11.
5
A video-atlas of levodopa-induced dyskinesia in Parkinson's disease: terminology matters.帕金森病左旋多巴诱导性异动症的视频图谱:术语很重要。
Neurol Sci. 2024 Apr;45(4):1389-1397. doi: 10.1007/s10072-023-07209-6. Epub 2023 Nov 21.
6
Successful Treatment of Biphasic and Peak-dose Dyskinesia With Combined Unilateral Subthalamic Nucleus and Contralateral Globus Pallidus Interna Deep Brain Stimulation.联合单侧丘脑底核和对侧内侧苍白球深部脑刺激成功治疗双相和峰值剂量运动障碍
J Mov Disord. 2023 Jan;16(1):95-97. doi: 10.14802/jmd.22081. Epub 2022 Nov 10.
7
Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia.D1 和 D2 受体激动剂对左旋多巴诱导的运动障碍啮齿动物模型皮质基底节振荡的独特影响。
Neurotherapeutics. 2023 Jan;20(1):304-324. doi: 10.1007/s13311-022-01309-5. Epub 2022 Nov 7.
8
Does Dexmedetomidine Improve or Worsen Restless Leg Syndrome under Sedation: A Case Report and Extensive Review.右美托咪定在镇静状态下改善还是加重不安腿综合征:一例病例报告及全面综述
Case Rep Crit Care. 2022 Sep 5;2022:2447461. doi: 10.1155/2022/2447461. eCollection 2022.
9
Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction.利用随机森林技术整合各种蛋白质相似性,推断增强的药物-蛋白质矩阵,以提高药物-疾病关联预测。
Sci Prog. 2022 Jul-Sep;105(3):368504221109215. doi: 10.1177/00368504221109215.
10
Role of 5-HT1A Receptor in Vilazodone-Mediated Suppression of L-DOPA-Induced Dyskinesia and Increased Responsiveness to Cortical Input in Striatal Medium Spiny Neurons in an Animal Model of Parkinson's Disease.5-HT1A 受体在维拉唑酮抑制帕金森病动物模型中 L-多巴诱导的运动障碍和增加纹状体中间神经元皮质传入反应中的作用。
Molecules. 2021 Sep 24;26(19):5790. doi: 10.3390/molecules26195790.